GNRC Hospitals on Saturday, July 25, organised Summer CME 2026 – "Update on Headache" at the NEDFi Convention Centre in Guwahati, bringing together physicians, neurologists, postgraduate trainees and other healthcare professionals to discuss the latest developments in headache diagnosis and treatment.
Organised by the Department of Neurology, GNRC Hospitals, Dispur, in collaboration with the Guwahati branch of the Association of Physicians of India (API), the CME programme focused on recent advances in migraine management, Trigemino-Autonomic Cephalalgias (TACs), secondary headaches, red flag signs, neuroimaging and newer therapies, including CGRP-based treatments. Dr Anup Kumar Barman, Vice Chancellor of Srimanta Sankaradeva University of Health Sciences, attended the event as the chief guest, while GNRC Chairman and Managing Director Dr Nomal Chandra Borah was the chief patron.
The scientific programme featured two keynote sessions by leading headache specialists. Dr K Ravishankar, Consultant In-charge of The Headache and Migraine Clinics at Jaslok and Lilavati Hospitals, Mumbai, delivered a lecture on "The ABC… of TACs (Trigemino-Autonomic Cephalalgias)", while Prof. (Dr) Debashish Chowdhury, Vice Chairman and Academic Head of Neurology at BLK-Max Centre of Neurosciences, New Delhi, spoke on recent advances in migraine management. Both sessions were followed by interactive discussions with participants on emerging evidence and clinical practice.
The event also saw the presentation of the WSO Angels Diamond Award in recognition of GNRC's performance in the RES-Q Registry for stroke care. Members of the RES-Q Registry core team were felicitated during the programme.
The event also saw the presentation of the WSO Angels Diamond Award in recognition of GNRC's performance in the RES-Q Registry for stroke care. Members of the RES-Q Registry core team were felicitated during the programme.
Addressing the gathering, organising secretary and senior consultant neurologist Dr Nabajyoti Barkataky said headache disorders remain among the most common yet under-recognised conditions in clinical practice. He said the CME was aimed at equipping clinicians with the latest evidence on the diagnosis and management of migraine and TACs, including newer treatment options, ultimately benefiting patients across the region.
The programme concluded with a vote of thanks by Dr Alfarid Shahid Ali, followed by a networking dinner for delegates.